Skip to main content

Table 4 Age ≥ 65 years: eGFR (CKD-EPI) and ACR category prevalence of CKD in T2DM a

From: Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging

GFR category, ml/min/1.73 m2(CKD-EPI) Albuminuria category, mg/g
< 30 30-300 > 300 Rowc
N % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI)
G1 ≥ 90 120b 6.0 (4.7-7.3) 54 3.2 (2.2-4.1) 7 0.2 (0.0-0.3) 181 9.4 (7.9-10.9)
G2 60-89 448b 33.0 (30.3-35.8) 187 11.5 (9.5-13.6) 51 3.1 (2.0-4.1) 686 47.6 (44.4-50.8)
G3a 45-59 197 14.8 (12.6-17.0) 111 7.5 (5.9-9.2) 35 2.2 (1.2-3.2) 343 24.5 (21.6-27.4)
G3b 30-44 69 5.6 (4.2%-7.0) 68 4.4 (3.2-5.7) 31 2.1 (1.0-3.3) 168 12.2 (10.0-14.4)
G4 15-29 19 1.4 (0.6-2.2) 28 2.7 (1.4-4.0) 29 2.0 (0.9-3.1) 76 6.1 (4.5-7.8)
G5 < 15 d 0.1 (-0.1-0.2) d 0.0 (0.0-0.0) 10 0.2 (0.0-0.4) 12 0.3 (0.1-0.5)
Column N, % (95% CI) c 854 60.9 (58.2-63.7) 449 29.3 (26.4-32.2) 163 9.8 (7.5-12.0) 1466 100 (N/A)
  1. aAge adjusted to 2012 NHIS diabetes population.
  2. bDoes not meet CKD criteria based on eGFR or albuminuria.
  3. cSum of rows and columns may deviate due to rounding.
  4. dCell frequency suppressed when count < 3 to avoid potential identifiability and imprecision of estimates.